OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/22/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization195,354 mln
Float3,186 mln
Earnings Date08/05/2026
EPS
4.26
Solid
P / E
10.28
Fair value
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.56
Likely reliable
1-Year Forecast
53.85
Attractive
Relative Strength
34
/ 100
Underperforming
Business Description
Founded in Denmark in 1923, Novo Nordisk is a global pharmaceutical company best known for its treatments targeting diabetes and obesity, as well as rare conditions affecting the blood and hormonal system. The company develops and sells a range of medicines and delivery devices, including smart insulin pens and dosing tools, distributed across markets in North America, Europe, Asia, Latin America, and beyond.
